Share
Marinomed Biotech AG has been listed on the Vienna Stock Exchange since February 1st, 2019. The shares are listed in the standard market continuous segment (ISIN: ATMARINOMED6 · Symbol: MARI).
Investors & Owners
The current shareholder structure at Marinomed is as follows: the founders and management team of Marinomed are the core shareholders with around 25% of total shares (thereof ~ 2% free float). The shares of the long-term investor Acropora Beteiligungs GmbH in Liquidation have been taken over by its shareholders in equal parts (as per announcement on May 30, 2023). Approximately 70% of shares are in free float.
Marinomed is supported by several public funding bodies, including:
Österreichische Forschungsförderungs GmbH (FFG)
Austria Wirtschaftsservice GmbH (AWS)